ソウラスキー医療センターにおいて、肉腫および整形外科腫瘍学の分野で豊富な研究・臨床経験を持つ第一人者。
ペレス・シャロン医師は、ソウラスキー医療センターにおいて、腹腔内温熱化学療法（HIPEC）を含む高度な化学療法技術を専門としています。
Dr. David Sarid is a specialist in oncology and radiotherapy based in Israel with expertise in chemotherapy, radiotherapy, and biological cancer therapy. He has been educated in the UK, Israel, and Georgia and has written over 30 articles devoted to cancer treatment. He is a lecturer at Tel Aviv University and a member of several medical organizations.
Prof. Amit Tirosh is a senior endocrinologist and Head of the Neuroendocrine Tumors Service at Sheba Medical Center. He specializes in neuroendocrine tumors (NETs).
His work centers on hereditary NET syndromes. He is affiliated with the NIH in MEN1 research. He serves on an international VHL expert panel and helped write VHL management guidelines. He is the primary contact at Sheba’s multidisciplinary VHL clinic.
He leads the Endocrine Oncology Bioinformatics Lab. He collaborates with international teams, including the Weizmann Institute. He provides advanced NET care, including PRRT.
He earned his MD from the Hebrew University–Hadassah. He completed a residency at Assaf HaRofeh, an endocrinology fellowship at Rabin, and training at the NIH. He is board-certified in Endocrinology. He is a member of the Israeli Society of Endocrinology, the Endocrine Society, and the European Neuroendocrine Tumor Society. He has authored over 40 peer-reviewed papers, including in JAMA, Gastroenterology, and Radiology.
スーラスキー医療センター腫瘍内科部長 – ウォルフ医師は高度な化学療法治療を専門としています。
アリ・ラファエル教授――テルアビブ・スラスキー医療センター（イキロフ、テルアビブ）トランスレーショナル腫瘍学部門長および臨床がん研究部門研究員。患者一人ひとりのニーズに寄り添う個別対応のアプローチが高く評価されています。
資格および患者への貢献：
腫瘍科デイホスピタルを統括し、国家ゲノム医療プロジェクトを主導。最先端の研究へのアクセスを提供しています。
主任副研究者および主任研究者として、腫瘍内mRNA投与やウイルス製剤を含むフェーズI〜IIIの多数の臨床試験に携わってきました。患者は革新的な治療法への参加機会を得られます。
米国および英国における国際的な臨床経験を有し、世界水準の治療基準と先進的なプロトコルの適用を保証しています。
国際学術団体の会員（ESMO、IASLC、ISLB、ISCORT、Israeli Medical Association）。最新の治療基準を活用し、国際的な研究に参画しています。
ICH GCP R2、Israeli MOH Guidelinesをはじめ、インフォームドコンセント、副作用管理および患者安全に関する最新課程を含む国際臨床実践基準に基づき、定期的に専門知識の更新および研修を実施しています。
ラファエル教授は、精密な治療レジメンの選択、革新的手法の導入、そして細やかな患者対応により高い信頼を得ており、治療のすべての段階において患者が安心して療養に臨める環境を提供しています。
Dr. Michael Shapira is a specialist in Bone Marrow Transplantation with over 20 years of experience. He graduated from the Hebrew University Medical School in 1999. He completed his training in internal medicine at Hadassah Medical Center.
Dr. Shapira is a senior physician in the Bone Marrow Transplantation department at Hadassah. He has played a key role in many successful transplants and has helped maintain high patient survival rates. He is known for his clinical skills and commitment to improving transplantation medicine.
Dr. Irina Stepfansky is an oncologist and internal medicine specialist at Sourasky Medical Center. She has more than 25 years of clinical experience. Since 2015, she has directed the Oncology Hospitalization department. Dr. Stepfansky earned her medical degree from Grodno University in Belarus. She completed advanced oncology training at Tel Aviv Medical Center.
Dr. Stepfansky has been licensed in Israel since 2000. She has led and participated in many phase I-III oncology clinical trials. Her work has helped improve cancer care and patient outcomes. She is recognized for her expertise in both internal medicine and oncology. Dr. Stepfansky has a strong record in research and clinical leadership.
Dr. Dror Levin is a senior pediatrician and director of the blood disorder and bone cancer (sarcoma) treatment departments at Children's Hospital "Dana" and Medical Center "Sourasky" respectively. He is a specialist in pediatric medicine, hematology, and oncology, with additional experience studying abroad at the Rizzoli Orthopaedic Institute in Italy.
Director, Bone Marrow Transplantation Department – Sheba Medical Center
Prof. Avichai Shimoni is a globally recognized hemato-oncologist with over 30 years of experience, specializing in bone marrow transplantation (BMT), cellular therapies, and advanced treatment of blood cancers.
As Director of the Bone Marrow Transplantation Department at Sheba Medical Center, he leads one of the most advanced and high-volume transplant programs in the region, treating patients with complex and high-risk hematologic malignancies.
Prof. Shimoni completed advanced fellowship training in Bone Marrow Transplantation at MD Anderson Cancer Center, one of the world’s leading oncology institutions.
His clinical approach focuses on:
Prof. Shimoni plays a key role in training future hematologists and advancing clinical research in transplantation and cellular therapy.
Prof. Shimoni is known for treating complex, high-risk cases, offering patients access to:
His work bridges clinical practice and research, ensuring patients benefit from the latest medical advancements.
Prof. Shimoni provides highly specialized, personalized care, focusing on:
Through his leadership in bone marrow transplantation and CAR-T therapy, Prof. Shimoni offers patients access to one of the most advanced and comprehensive blood cancer treatment programs worldwide.
Director, Institute of Hematology & Co-Director, Hematology and Bone Marrow Transplantation Division – Sheba Medical Center
Dr. Abraham Avigdor is a highly distinguished hemato-oncologist with over 35 years of experience, specializing in the treatment of lymphomas, multiple myeloma, and complex blood cancers.
As Director of the Institute of Hematology at Sheba Medical Center, he leads one of the region’s most advanced programs in bone marrow transplantation and cellular therapies, including CAR-T treatment.
Dr. Avigdor is internationally recognized for advancing modern lymphoma care, focusing on:
His work has helped shape the use of CAR-T therapy as a standard option in advanced hematologic cancers.
Dr. Avigdor collaborates with leading global research groups, including:
He has authored 130+ scientific publications, contributing significantly to advancements in lymphoma treatment and cellular therapies.
Dr. Avigdor combines decades of experience, global leadership, and cutting-edge therapies to provide highly personalized care for patients with complex blood cancers.
His approach focuses on:
Through his leadership in CAR-T therapy, bone marrow transplantation, and lymphoma research, Dr. Avigdor offers patients access to one of the most advanced and comprehensive blood cancer programs globally.
Professor Raanan Berger, MD PhD, is a medical oncologist and radiotherapist. He is Director of the Cancer Center at Sheba Medical Center and heads its clinical research unit. He was listed in Forbes Israel’s “Best Doctors” (2025). He leads the genitourinary oncology program with a focus on prostate cancer. His care includes systemic therapy and radiotherapy in a multidisciplinary, patient-centered model.
He is board-certified in oncology. He earned his MD and PhD at Tel Aviv University and completed his clinical training at Sheba. He then completed a postdoctoral fellowship at Dana-Farber/Harvard, focusing on prostate cancer with Dr. Philip Kantoff and molecular oncology in Dr. William C. Hahn’s lab. He is a member of ESMO and ASCO. He has co-authored more than 20 peer-reviewed papers, including studies on outcomes in high- versus very high-risk prostate cancer and on BRCA1/2 in large cohorts.
Dr. Yuri Goldes is a general surgeon with more than 20 years of clinical experience. He specializes in upper gastrointestinal and oncologic surgery. He is Deputy Director of the Department of General Surgery and Transplantation at Sheba Medical Center in Tel Aviv. He also leads the Upper GI Surgery Unit. He was named to Forbes Israel’s Best Doctors in 2025. He is ranked among Israel’s Best Gastrointestinal Surgeons by Forbes. In 2019, he received the Israeli Ministry of Health “Best Doctor of the Year” award.
He is an expert in advanced minimally invasive and robotic surgery. He treats diaphragmatic hernia, achalasia, GERD, and gallbladder disease. He also performs oncologic surgery for pancreatic, gastric, and esophageal cancers. He uses laparoscopic and robotic techniques.
He pioneered some of Israel’s first robotic oncologic resections of the stomach and pancreas. He is among a small group worldwide who perform minimally invasive Whipple procedures (pancreaticoduodenectomy) using advanced laparoscopy. He applies methods that improve outcomes and speed recovery. He provides personalized care.
Prof. Ben Boursi is a physician in the Gastrointestinal Cancer Department at Sheba Medical Center. He specializes in internal medicine, medical oncology, and cancer epidemiology. He is board certified in internal medicine and medical oncology. He earned a B.Med.Sc (summa cum laude) and an MD (magna cum laude) from Tel Aviv University.
He completed clinical and research fellowships in GI oncology and cancer epidemiology at the University of Pennsylvania. He also completed electives at MD Anderson and Mayo Clinic. He founded the ECOG-ACRIN Microbiome Working Group. His microbiome-oncology research has been published in leading journals, including Science, and highlighted by ASCO.
He developed predictive models for early diagnosis of colorectal and pancreatic cancers. These models are now in clinical evaluation. He holds an academic appointment at Tel Aviv University. He is also an Associate Scholar at the University of Pennsylvania.
Jair Bar, MD, PhD, Professor
Thoracic Oncologist | Deputy Director of Cancer Center | Lung Cancer Specialist
Areas of Expertise
Professor Jair Bar specializes in thoracic oncology, with a strong focus on advanced lung cancer treatment and translational research:
Lung Cancer (non-small cell and advanced stages)
Thoracic Oncology
Medical Oncology & Radiotherapy
Molecular Biology & Genetics in Cancer
Immunotherapy and Resistance Mechanisms
Translational Oncology Research
About the Doctor
Professor Jair Bar is a leading thoracic oncologist and serves as the Deputy Director of the Cancer Center at Sheba Medical Center.
He also heads the Thoracic Oncology Unit, where he focuses on the treatment of lung cancer using advanced systemic therapies, including immunotherapy and targeted treatments.
In addition to his clinical work, Prof. Bar leads a research laboratory dedicated to studying resistance to immunotherapy, contributing to the development of more effective cancer treatment strategies.
He combines clinical expertise with cutting-edge research, ensuring that patients benefit from the most up-to-date therapeutic approaches.
Clinical Approach
Personalized cancer treatment based on molecular and genetic profiling
Integration of immunotherapy, targeted therapy, and radiotherapy
Multidisciplinary decision-making for complex cases
Focus on improving survival outcomes and quality of life
Positions
Deputy Director, Cancer Center, Sheba Medical Center
Head of Thoracic Oncology Unit
Chair, Israel Lung Cancer Group (since 2003)
Senior Lecturer, Tel Aviv University
Professional Memberships
Member of Israel Society of Clinical Oncology and Radiotherapy
Member of American Society of Clinical Oncology
Member of American Association for Cancer Research
Education and Training
MD, Hebrew University of Jerusalem (Hadassah Medical School)
PhD in Molecular Biology, Weizmann Institute of Science
Board Certifications
Medical Oncology
Radiotherapy Oncology
Research & Publications
Professor Bar is actively involved in translational and clinical research, with publications focused on lung cancer biology and treatment, including:
Cancer metabolism in lung cancer based on exhaled breath analysis
Angiogenesis inhibition strategies in lung cancer therapy
He continues to contribute to advancing precision oncology and immunotherapy approaches in thoracic cancers.
| 順位 | 医師 | 経験 | 適合する方 | 特色 | クリニックと所在地 | 診察 |
|---|---|---|---|---|---|---|
| #1 | 41年の経験 | 肉腫および骨腫瘍 | 希少な軟部腫瘍および骨腫瘍を専門とし、専門サルコーマユニットを統括。ESMOファカルティメンバーであり、パリの主要がんセンターにて高度な研修を修了。 | イスラエル | から $950 | |
| #2 | 23年の経験 | 高度化学療法技術 | HIPECおよび個別化化学療法プロトコルを専門とする。治療に対する患者の理解向上を目的とした臨床研究を実施している。 | イスラエル | から $825 | |
| #3 | 34年の経験 | 化学療法の高度な治療 | 主要病院の腫瘍内科部門を統括し、臨床的専門知識と化学療法プロトコールの策定におけるリーダーシップを兼ね備えている。国際患者に対応するため英語に堪能。 | イスラエル | お問い合わせください |